This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Nanocopoeia, LLC. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Limin Shi: Innovator in Pharmaceutical Compositions
Introduction
Limin Shi is a notable inventor based in Minnetonka, MN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on improving the efficacy and administration of medications, which can have a profound impact on patient care.
Latest Patents
Limin Shi holds a patent for an orally disintegrating tablet comprising an amorphous solid dispersion of nilotinib. This invention, titled "Amorphous solid dispersions and pharmaceutical compositions of the protein kinase inhibitor nilotinib," presents a novel approach to treating proliferative disorders such as cancer. The pharmaceutical compositions developed by Shi can be administered without regard to food consumption, offering flexibility for patients. Additionally, these compositions can be given at significantly lower doses compared to existing formulations, while still providing comparable therapeutic effects. He has 1 patent to his name.
Career Highlights
Limin Shi is associated with Nanocopoeia, LLC, where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative drug delivery systems that enhance patient compliance and treatment outcomes.
Collaborations
Limin Shi collaborates with talented individuals such as Tzehaw Chen and Sarah M Rieschl. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical innovations.
Conclusion
Limin Shi's contributions to the field of pharmaceuticals, particularly through his patented innovations, demonstrate his commitment to improving treatment options for patients. His work is a testament to the importance of innovation in healthcare.